Dr. John Cush RheumNow
4 years 10 months ago
Real Time Monitoring of Disease Activity? There's An App for That: Dr. Akhil Sood ( @AkhilSoodMD) discusses abstracts #0811 and #0373 presented at the #ACR21 annual meeting.
https://t.co/2qeZjhtMU4 https://t.co/MPCA3oox1U
My research shows that up to 50% of rheumatologists measure something in the course of their daily assessments, and RAPID3 is most popular, being employed by 31% of rheumatologists.
Dr. John Cush RheumNow
4 years 10 months ago
Emerging Therapies in Psoriatic Arthritis: Drs. Antoni Chan ( @synovialjoints) interviews Dr. FitzGerald about abstract #0490 and other PsA highlights being presented at the #ACR21 annual meeting.
https://t.co/WVgcE8TVpZ https://t.co/1uOafjFWPg
Dr. John Cush RheumNow
4 years 10 months ago
RAPID3 in Psoriatic Arthritis: Dr. Meral El Ramahi ( @MeralElRamahiMD) reports on abstract #0633 presented at the #ACR21 annual meeting.
https://t.co/DO7YXhD3YA https://t.co/vcegdPx8OL
Dr. John Cush RheumNow
4 years 10 months ago
First JAKi Failure: What next? Dr. Aurelie Najm ( @AurelieRheumo) discusses abstract #1442 presented at the #ACR21 annual meeting.
https://t.co/NCO8VeNsjb https://t.co/bSN34AFTtt
Dr. John Cush RheumNow
4 years 10 months ago
Career Advice for Young Rheumatologists: Drs. Janet Pope ( @Janetbirdope) asks Dr. Bykerk for her career advice for young rheumatologists, during the #ACR21 annual meeting.
https://t.co/jv0eYeFR7M https://t.co/WfYFXPwMtI
Dr. John Cush RheumNow
4 years 10 months ago
Drs. Jack Cush and the RheumNow Faculty Drs. David Liew, Swetha Ann Alexander, Meral El Ramahi, Mrinalini Dey and Robert Chao, discuss highlights from Day 2 at the #ACR21 meeting.
https://t.co/jWDeA2aZqJ
@drdavidliew @swethaann23 @MeralElRamahiMD @DrMiniDey @doctorRBC https://t.co/KcE67BXcvp
Dr. John Cush RheumNow
4 years 10 months ago
TNF Inhibitors Rise to the Top: Drs. Janet Pope ( @Janetbirdope) and David Liew ( @drdavidliew) discuss TNF inhibitor data presented at the #ACR21 annual meeting, including abstracts #0087, #0990 and #0958.
https://t.co/G02P1vG7VQ https://t.co/BLZX5BPzEF
Dr. John Cush RheumNow
4 years 10 months ago
Data from ASN Kidney Wk 2021; US Renal Data System of 275,651 dialysis pts - 15% had gout Vs 85% without gout; Gout pts were older, more male, obese, had more hospitalizations (66 vs 57%), mortality, more CVD, PVD and MI https://t.co/m1d0SJEJjw
Dr. John Cush RheumNow
4 years 10 months ago
Best of SpA Abstracts Day 2: Dr. Robert Chao ( @doctorRBC) shares the best of SpA Abstracts from Day 2 of #ACR21.
https://t.co/8oZipxMLCm https://t.co/jAifqBRgVc
There were several hot topics at ACR21. Here I concentrate on top abstracts in vasculitis.
Dr. John Cush RheumNow
4 years 10 months ago
Early Rheumatoid Arthritis: Dr. Janet Pope ( @Janetbirdope) interviews Dr. Vivian Bykerk about her work in early RA and CATCH (Canadian Early Arthritis Cohort) Study Group, during the #ACR21 annual meeting.
https://t.co/DGazNdTFTU https://t.co/K318MIkxvy
The GLORIA study (ABST# 1678) was a pragmatic, blinded placebo-controlled randomized trial from Dr. Martin Boers and colleagues where they assessed whether prednisolone (vs. placebo) use would alter clinical outcomes over 2 years.
Dr. John Cush RheumNow
4 years 10 months ago
Vitamin D and Hydroxychloroquine Studies: Dr. Michelle Petri discussed studies regarding Vitamin D supplementation and as well as data on hydroxychloroquine that was presented Saturday at the #ACR21 annual meeting.
https://t.co/CU8wFVYhNg
